SARS-CoV-2 Infection in Dogs and Cats is Associated with Contact to COVID-19-positive Household Members
Overview
Authors
Affiliations
Several domestic and wild animal species are susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Reported (sero)prevalence in dogs and cats vary largely depending on the target population, test characteristics, geographical location and time period. This research assessed the prevalence of SARS-CoV-2-positive cats and dogs (PCR- and/or antibody positive) in two different populations. Dogs and cats living in a household with at least one confirmed COVID-19-positive person (household (HH) study; 156 dogs and 152 cats) and dogs and cats visiting a veterinary clinic (VC) (VC study; 183 dogs and 140 cats) were sampled and tested for presence of virus (PCR) and antibodies. Potential risk factors were evaluated and follow-up of PCR-positive animals was performed to determine the duration of virus shedding and to detect potential transmission between pets in the same HH. In the HH study, 18.8% (27 dogs, 31 cats) tested SARS-CoV-2 positive (PCR- and/or antibody positive), whereas in the VC study, SARS-CoV-2 prevalence was much lower (4.6%; six dogs, nine cats). SARS-CoV-2 prevalence amongst dogs and cats was significantly higher in the multi-person HHs with two or more COVID-19-positive persons compared with multi-person HHs with only one COVID-19-positive person. In both study populations, no associations could be identified between SARS-CoV-2 status of the animal and health status, age or sex. During follow-up of PCR-positive animals, no transmission to other pets in the HH was observed despite long-lasting virus shedding in cats (up to 35 days). SARS-CoV-2 infection in dogs and cats appeared to be clearly associated with reported COVID-19-positive status of the HH. Our study supports previous findings and suggests a very low risk of pet-to-human transmission within HHs, no severe clinical signs in pets and a negligible pet-to-pet transmission between HHs.
SARS-CoV-2 nsp1 mediates broad inhibition of translation in mammals.
Gen R, Addetia A, Asarnow D, Park Y, Quispe J, Chan M bioRxiv. 2025; .
PMID: 39868184 PMC: 11761087. DOI: 10.1101/2025.01.14.633005.
Humer E, Winter S, Probst T, Pieh C, Dale R, Bruhl D Front Vet Sci. 2024; 11:1460269.
PMID: 39568480 PMC: 11576337. DOI: 10.3389/fvets.2024.1460269.
Kimmerlein A, McKee T, Bergman P, Sokolchik I, Leutenegger C Viruses. 2024; 16(7).
PMID: 39066319 PMC: 11281334. DOI: 10.3390/v16071157.
Daigle L, Khalid H, Gagnon C, Arsenault J, Bienzle D, Bisson S BMC Vet Res. 2024; 20(1):304.
PMID: 38982461 PMC: 11232172. DOI: 10.1186/s12917-024-04150-4.
Venkat H, Yaglom H, Hecht G, Goedderz A, Ely J, Sprenkle M Pathogens. 2024; 13(6).
PMID: 38921764 PMC: 11206992. DOI: 10.3390/pathogens13060466.